239 related articles for article (PubMed ID: 26016703)
1. Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases.
Zhu H; Dong D; Li F; Liu D; Wang L; Fu J; Song L; Xu G
Int J Dermatol; 2015 Dec; 54(12):1390-5. PubMed ID: 26016703
[TBL] [Abstract][Full Text] [Related]
2. Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey.
Mikkelsen LH; Larsen AC; von Buchwald C; Drzewiecki KT; Prause JU; Heegaard S
APMIS; 2016 Jun; 124(6):475-86. PubMed ID: 27004972
[TBL] [Abstract][Full Text] [Related]
3. Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.
Mücke T; Hölzle F; Kesting MR; Loeffelbein DJ; Robitzky LK; Hohlweg-Majert B; Tannapfel A; Wolff KD
J Oral Maxillofac Surg; 2009 Jul; 67(7):1409-15. PubMed ID: 19531410
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of oral mucosal melanoma: histopathological analysis in a retrospective cohort of 82 cases.
Song H; Wu Y; Ren G; Guo W; Wang L
Histopathology; 2015 Oct; 67(4):548-56. PubMed ID: 25809697
[TBL] [Abstract][Full Text] [Related]
5. Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
Kim HS; Kim EK; Jun HJ; Oh SY; Park KW; Lim DH; Lee SI; Kim JH; Kim KM; Lee DH; Lee J
BMC Cancer; 2010 Apr; 10():167. PubMed ID: 20426858
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
7. Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades.
Kirchoff DD; Deutsch GB; Foshag LJ; Lee JH; Sim MS; Faries MB
Am Surg; 2016 Jan; 82(1):1-5. PubMed ID: 26802836
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
9. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
[TBL] [Abstract][Full Text] [Related]
10. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
11. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
12. Treatment and prognosis of oral mucosal melanoma.
Sun CZ; Chen YF; Jiang YE; Hu ZD; Yang AK; Song M
Oral Oncol; 2012 Jul; 48(7):647-52. PubMed ID: 22349277
[TBL] [Abstract][Full Text] [Related]
13. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
14. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
15. Anal versus rectal melanoma: does site of origin predict outcome?
Bello DM; Smyth E; Perez D; Khan S; Temple LK; Ariyan CE; Weiser MR; Carvajal RD
Dis Colon Rectum; 2013 Feb; 56(2):150-7. PubMed ID: 23303142
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in patients with mucosal melanomas.
Keller DS; Thomay AA; Gaughan J; Olszanski A; Wu H; Berger AC; Farma JM
J Surg Oncol; 2013 Dec; 108(8):516-20. PubMed ID: 24132665
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.
Hao M; Zhao G; Du X; Yang Y; Yang J
Tumour Biol; 2016 Aug; 37(8):10339-48. PubMed ID: 26846098
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors in malignant melanoma of the conjunctiva. An anatomo-clinical study of 56 patients].
Desjardins L; Poncet P; Levy C; Schlienger P; Asselain B; Validire P
J Fr Ophtalmol; 1999 Apr; 22(3):315-21. PubMed ID: 10337587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
